SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Sold by Global Retirement Partners LLC

Global Retirement Partners LLC lowered its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 14.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,902 shares of the exchange traded fund’s stock after selling 842 shares during the quarter. Global Retirement Partners LLC’s holdings in SPDR S&P Biotech ETF were worth $441,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of XBI. Healthcare of Ontario Pension Plan Trust Fund boosted its holdings in shares of SPDR S&P Biotech ETF by 198.6% in the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock valued at $911,825,000 after acquiring an additional 6,138,000 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd purchased a new stake in SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $141,284,000. Mirae Asset Securities USA Inc. increased its position in SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after purchasing an additional 300,000 shares during the period. Assetmark Inc. raised its stake in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares in the last quarter. Finally, Sivik Global Healthcare LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the 3rd quarter valued at approximately $29,640,000.

SPDR S&P Biotech ETF Stock Down 1.1 %

Shares of NYSEARCA XBI opened at $91.70 on Monday. The stock has a market capitalization of $6.99 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52 week low of $81.14 and a 52 week high of $105.47. The firm has a 50-day moving average price of $91.36 and a 200 day moving average price of $96.00.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.